Largely beneficial to critically or severely ill COVID-19 patients: report reveals
New Delhi, August 22, 2020: Despite tireless efforts of researchers and doctors across the world, no vaccine or medicine has come up yet to cure or to curb this global pandemic. It has taken away millions of lives and is consistently bringing new life-threatening conditions. Cytokine Storm is one of such conditions, which turns against the immune system fuelling COVID-19 infection, posing threat to life.
Cytokines can be very harmful to the body if released at once in large numbers. WhileCytokine Storms include infections, autoimmune conditions or other such diseases. Or may even occur after the utilisation of some immunotherapy for treatment. Basic symptoms include — high fever, inflammation, severe fatigue and nausea. Certain cytokines can also trigger cell death. When this happens, many cells begin to die at the same time, leading to the destruction of the entire tissue.
Adding further, Dr Bhalla said, “In the case of COVID-19, a Cytokine Storm is highly likely to damage the lung tissues. When this happens, respiratory distress syndrome follows, and the organ begins to fail. A similar process is followed by the rest of the organs as well, leading to an event known as ‘multi-organ failure’ which results in death.”(Goodman, 2020)
While Cytokine Storms can surely be deadly in nature, several strategies for its control have been devised since the outbreak of COVID-19. On one hand, regular monitoring and assessment of Cytokine levels in the body may prove to be beneficial and can guide the clinician on the use of targeted therapies.
Blood purificationhas also proved to be beneficial when it comes to the management of such cytokine storms. Several strategies for blood purification are in use now to control the deadly phenomenon-these include plasma exchange, absorption, perfusion, blood/plasma filtration etc. (Ye, Wang, & Mao, 2020)
Filters to manage Cytokine Storms can play significant role in managing COVID-19 patients who are critically or severely ill. Early reports from China have revealed that up to 20% of COVID-19 patients may fall under this criterion (Topfer, 2020).
“In such a crucial time, when COVID-19 cases in India have been increasing exponentially, Oxiris filter of Baxter India has received an extension of indication from the Central Drugs Standard Control Organization (CDSCO) under Directorate General of Health Services, Ministry of Health & Family Welfare, India. The availability of Oxiris filter set in India may help the medical fraternity to fight theCOVID-19 pandemic in a more organised way”,added Dr Gupta.(https://health.economictimes.indiatimes.com/).
The Oxiris Filter set is helpful in blood purificationfor patients who are highly susceptible to additional organ dysfunctions due to high levels of circulating cytokines. During blood purification therapy, the Oxiris Filter helps by adsorbing the inflammatory mediators and removing fluids, electrolytes, and uremic toxins when the blood passes through the filter. An added advantage of using this filter for blood purification is that it does not require any additional devices for kidney support or in other words dialysis whichcan help reduce unnecessary puncturing of patients body.
As the COVID-19 cases have been rising exponentially in India, and the recent spike is beyond speculation. This is a testing time when we require every asset — lock, stock and barrel to combat this. In such a situation, the availability of Oxiris filter will be the milestone in the management of the cytokine storm. The Oxiris filter is also expected to help make the treatment process smoother and easier to navigate. Hopefully, with the increased use of this filter, more lives can be saved.
References
Goodman, B. (2020). Cytokine Storms May Be Fueling Some COVID Deaths. WebMD.
https://health.economictimes.indiatimes.com/news/pharma/baxter-india-gets-cdsco-approval-for-its-oxiris-filter-for-covid-19-treatment/76849138
Topfer, L.-A. (2020). Blood Purification Using Cytokine Adsorbers to Reduce Cytokine Storm in Severe COVID-19 Illness. CADTH .
Ye, Q., Wang, B., & Mao, J. (2020). The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. PubMed.
Zhang, J.-M., & An, J. (2009). Cytokines, Inflammation and Pain. PubMed Central.
Corporate Comm India (CCI Newswire)
· World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…
Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Winter weather brings a host…
By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…
Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…
Coimbatore, October 30, 2024: Sri Ramakrishna Hospital’s Neurology experts observes “World Stroke Day” on October…